Home/Filings/4/0000950170-24-006671
4//SEC Filing

Sanchez Ramiro 4

Accession 0000950170-24-006671

CIK 0001805387other

Filed

Jan 22, 7:00 PM ET

Accepted

Jan 23, 5:34 PM ET

Size

5.8 KB

Accession

0000950170-24-006671

Insider Transaction Report

Form 4
Period: 2024-01-19
Sanchez Ramiro
Chief Medical Officer
Transactions
  • Award

    Restricted Stock Units

    2024-01-19+87,57387,573 total
    Common Stock (87,573 underlying)
Footnotes (1)
  • [F1]The shares reported in this transaction represent Restricted Stock Units ("RSUs") granted under the Cerevel Therapeutics Holdings, Inc. 2020 Equity Incentive Plan (the "Plan"). Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments on each of January 19, 2025, January 19, 2026, January 19, 2027 and January 19, 2028, subject to the Reporting Person's continued service on each such vesting date.

Documents

1 file

Issuer

Cerevel Therapeutics Holdings, Inc.

CIK 0001805387

Entity typeother

Related Parties

1
  • filerCIK 0001830326

Filing Metadata

Form type
4
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 5:34 PM ET
Size
5.8 KB